Prostatic effects of cis-diamine-chloroplatinum in the dog.
D000135:Acid Phosphatase / Q000378:metabolism; D000469:Alkaline Phosphatase / Q000378:metabolism; D000588:Amines / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D001835:Body Weight / Q000187:drug effects; D002369:Castration; D002712:Chlorides / Q000494:pharmacology; D004285:Dogs; D004964:Estriol / Q000378:metabolism; D007275:Injections, Intravenous; D008297:Male; D009942:Organometallic Compounds / Q000008:administration & dosage; D009994:Osmolar Concentration; D010984:Platinum; D011467:Prostate / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism / Q000502:physiology; D011485:Protein Binding / Q000187:drug effects; D013739:Testosterone / Q000378:metabolism; D013997:Time Factors
D000588:Amines; D000970:Antineoplastic Agents; D002712:Chlorides; D009942:Organometallic Compounds; D013739:Testosterone; D010984:Platinum; D000469:Alkaline Phosphatase; D000135:Acid Phosphatase; D004964:Estriol